Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Reply

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)1405-1406
Number of pages2
JournalJournal of thrombosis and haemostasis : JTH
Volume17
Issue number8
DOIs
Publication statusPublished - Aug 1 2019

ASJC Scopus subject areas

  • Hematology

Cite this

@article{063667ecf1864e82a39eed7fe093bf62,
title = "Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery: Reply",
author = "Flora Peyvandi",
year = "2019",
month = "8",
day = "1",
doi = "10.1111/jth.14545",
language = "English",
volume = "17",
pages = "1405--1406",
journal = "Journal of Thrombosis and Haemostasis",
issn = "1538-7933",
publisher = "Wiley-Blackwell",
number = "8",

}

TY - JOUR

T1 - Phase 3 study of recombinant von Willebrand factor in patients with severe von Willebrand disease who are undergoing elective surgery

T2 - Reply

AU - Peyvandi, Flora

PY - 2019/8/1

Y1 - 2019/8/1

UR - http://www.scopus.com/inward/record.url?scp=85070932333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070932333&partnerID=8YFLogxK

U2 - 10.1111/jth.14545

DO - 10.1111/jth.14545

M3 - Letter

C2 - 31368219

AN - SCOPUS:85070932333

VL - 17

SP - 1405

EP - 1406

JO - Journal of Thrombosis and Haemostasis

JF - Journal of Thrombosis and Haemostasis

SN - 1538-7933

IS - 8

ER -